NIST Center for Neutron Research , National Institute of Standards and Technology , 100 Bureau Drive , Mail Stop 6102, Gaithersburg , Maryland 20899 , United States.
Institute for Bioscience and Biotechnology Research , University of Maryland , 9600 Gudelsky Drive , Rockville , Maryland 20850 , United States.
Mol Pharm. 2019 Oct 7;16(10):4319-4338. doi: 10.1021/acs.molpharmaceut.9b00687. Epub 2019 Sep 24.
Excipients are substances that are added to therapeutic products to improve stability, bioavailability, and manufacturability. Undesirable protein-protein interactions (PPI) can lead to self-association and/or high solution viscosity in concentrated protein formulations that are typically greater than 50 mg/mL. Therefore, understanding the effects of excipients on nonspecific PPI is important for more efficient formulation development. In this study, we used National Institute of Standards and Technology monoclonal antibody (NISTmAb) reference material as a model antibody protein to examine the physical stability and viscosity of concentrated formulations using a series of excipients, by varying pH, salt composition, and the presence of cosolutes including amino acids, sugars, and nonionic surfactants. Small angle X-ray scattering (SAXS) together with differential scanning calorimetry (DSC), dynamic light scattering (DLS), and viscosity measurements were used to obtain various experimental parameters to characterize excipient modulated PPI and bulk solution viscosities. In particular, a good correlation was found between SAXS and DLS/SLS results, suggesting that the use of DLS/SLS is valid for predicting the colloidal stability of NISTmAb in concentrated solutions. Moreover, further analysis of effective structure factor measured from SAXS enabled the dissection of net PPI into hydrodynamic forces due to excluded volume as well as any additional attractive or repulsive interactions with the presence of excipients. It was found that although no denaturation or aggregation of NISTmAb was observed and that the net PPI were repulsive, the use of ionic excipients such as pH and salts leads to increased short-range attraction, whereas the nonionic excipients including sugars, amino acids, and polysorbate surfactants lead to increased repulsive PPI with increasing protein concentration. Results obtained from viscosity measurements showed that the use of excipients can lead to increased solution viscosities at high protein concentrations. The use of , interaction parameter , and second virial coefficient as predictors for solution viscosity was also evaluated by comparing the predicted results with the measured viscosities. Although and appeared to be better predictors than , disagreement between the predicted and measured results suggests other factors apart from PPI contribute to the bulk rheological properties of concentrated protein solutions.
辅料是添加到治疗产品中的物质,以提高其稳定性、生物利用度和可制造性。不理想的蛋白质-蛋白质相互作用(PPI)会导致在浓度大于 50mg/mL 的浓缩蛋白质制剂中发生自缔合和/或高溶液黏度。因此,了解辅料对非特异性 PPI 的影响对于更有效的配方开发非常重要。在这项研究中,我们使用美国国家标准与技术研究院单克隆抗体(NISTmAb)参考物质作为模型抗体蛋白,通过改变 pH 值、盐组成以及存在包括氨基酸、糖和非离子表面活性剂在内的共溶剂,使用一系列辅料来检查浓缩制剂的物理稳定性和黏度。使用小角 X 射线散射(SAXS)结合差示扫描量热法(DSC)、动态光散射(DLS)和黏度测量来获得各种实验参数,以表征辅料调节的 PPI 和体相溶液黏度。特别是,发现 SAXS 和 DLS/SLS 结果之间存在良好的相关性,表明 DLS/SLS 的使用可用于预测 NISTmAb 在浓缩溶液中的胶体稳定性。此外,从 SAXS 测量的有效结构因子的进一步分析,使得可以将净 PPI 分解为由于排除体积引起的流体力学力以及在存在辅料时的任何额外的吸引或排斥相互作用。结果发现,尽管没有观察到 NISTmAb 的变性或聚集,并且净 PPI 是排斥的,但是使用离子辅料(如 pH 值和盐)会导致短程吸引力增加,而包括糖、氨基酸和聚山梨醇酯表面活性剂在内的非离子辅料会导致随着蛋白质浓度的增加,排斥性 PPI 增加。黏度测量结果表明,在高蛋白质浓度下使用辅料会导致溶液黏度增加。还通过将预测结果与测量黏度进行比较,评估了 、相互作用参数 和第二维里系数 作为溶液黏度预测因子的作用。尽管 和 似乎比 更好的预测因子,但预测结果与测量结果之间的不一致表明,除了 PPI 之外,其他因素也会影响浓缩蛋白质溶液的整体流变性质。